(Q51782145)

12 April 2018

title

Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II. (English)

1 reference

12 April 2018

author name string

E M Oestreicher

1

1 reference

12 April 2018

C Guo

2

1 reference

12 April 2018

E W Seely

3

1 reference

12 April 2018

T Kikuchi

4

1 reference

12 April 2018

D Martinez-Vasquez

5

1 reference

12 April 2018

L Jonasson

6

1 reference

12 April 2018

T Yao

7

1 reference

12 April 2018

D Burr

8

1 reference

12 April 2018

S Mayoral

9

1 reference

12 April 2018

W Roubsanthisuk

10

1 reference

12 April 2018

V Ricchiuti

11

1 reference

12 April 2018

G K Adler

12

1 reference

12 April 2018

language of work or name

English

0 references

publication date

4 October 2006

1 reference

12 April 2018

published in

Kidney International

1 reference

12 April 2018

volume

70

1 reference

12 April 2018

issue

10

1 reference

12 April 2018

page(s)

1759-1768

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001897

exact match

0 references

cites work

Estrogen and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

HRT does not improve urinary albumin excretion in postmenopausal diabetic women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Renal characteristics and effect of angiotensin suppression in oral contraceptive users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estrogen induces glomerulosclerosis in analbuminemic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Somatostatin analogue attenuates estrogen-induced augmentation of glomerular injury in spontaneous hypercholesterolemic female Imai rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estrogen accelerates the development of renal disease in female obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Phytoestrogens: implications in neurovascular research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estradiol is nephroprotective in the rat remnant kidney.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estrogen upregulates renal angiotensin II AT(2) receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estrogen regulates adrenal angiotensin type 1 receptors by modulating adrenal angiotensin levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Chronic estrogen treatment reduces angiotensin II receptors in the anterior pituitary.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Effect of oral contraceptives on the renin angiotensin system and renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Strategies and methods for research on sex differences in brain and behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Ovariectomy enhances renal cortical expression and function of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Female sex steroids increase adrenomedullin-induced vasodilation by increasing the expression of adrenomedullin2 receptor components in rat mesenteric artery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Aldosterone: a mediator of myocardial necrosis and renal arteriopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001897

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001897

1 reference

12 April 2018

PubMed ID

17021606

1 reference

12 April 2018